These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18520089)

  • 1. Design, synthesis and cytotoxicity of novel podophyllotoxin derivatives.
    Yu PF; Chen H; Wang J; He CX; Cao B; Li M; Yang N; Lei ZY; Cheng MS
    Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):831-4. PubMed ID: 18520089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of 4beta-amido and 4beta-sulphonamido analogues of podophyllotoxin as potential antitumour agents.
    Kamal A; Ashwini Kumar B; Arifuddin M; Dastidar SG
    Bioorg Med Chem; 2003 Nov; 11(23):5135-42. PubMed ID: 14604676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and antitumor activity of novel podophyllotoxin derivatives as potent anticancer agents.
    Liu J; Cao B; Gao Y; Bai M; Mei X; Chen H; Jiang YG; Huang DJ
    J Asian Nat Prod Res; 2013 Sep; 15(9):985-92. PubMed ID: 23859462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitumor activity of novel podophyllotoxin derivatives against multidrug-resistant cancer cells.
    Guo YE; Chen H; Zuo S; Liu DL; Lu YL; Lv JJ; Wen SP; Zhang TC
    J Asian Nat Prod Res; 2011 May; 13(5):417-24. PubMed ID: 21534039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 4α/4β-imidazolyl podophyllotoxin analogues as antitumor agents.
    Shang H; Chen H; Zhao D; Tang X; Liu Y; Pan L; Cheng M
    Arch Pharm (Weinheim); 2012 Jan; 345(1):43-8. PubMed ID: 21956645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
    Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
    Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological evaluation of novel spin-labeled derivatives of podophyllotoxin as potential antineoplastic agents. Part XII.
    Yang L; Liu YQ; Tan H; Li WG; Tian X
    Nat Prod Res; 2007 Sep; 21(11):998-1008. PubMed ID: 17691049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl ethers of podophyllotoxin-related cyclolignans.
    Miguel del Corral JM; Gordaliza M; Castro MA; Morales LJ; Lopez JL; San Feliciano A
    J Nat Prod; 1995 Jun; 58(6):870-7. PubMed ID: 7673931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
    Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
    Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activity of spin labeled derivatives of podophyllotoxin.
    Tian X; Wang YG; Yang MG; Chen YZ
    Life Sci; 1997; 60(8):511-7. PubMed ID: 9042385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and anti-HIV-1 activities of novel podophyllotoxin derivatives.
    Chen SW; Wang YH; Jin Y; Tian X; Zheng YT; Luo DQ; Tu YQ
    Bioorg Med Chem Lett; 2007 Apr; 17(7):2091-5. PubMed ID: 17317161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemi-synthesis and biological activity of new analogues of podophyllotoxin.
    Roulland E; Magiatis P; Arimondo P; Bertounesque E; Monneret C
    Bioorg Med Chem; 2002 Nov; 10(11):3463-71. PubMed ID: 12213460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Podophyllotoxin Derivatives as Potential Tubulin Inhibitors: Design, Synthesis, and Antiproliferative Activity Evaluation.
    Han HW; Lin HY; He DL; Ren Y; Sun WX; Liang L; Du MH; Li DC; Chu YC; Yang MK; Wang XM; Yang YH
    Chem Biodivers; 2018 Nov; 15(11):e1800289. PubMed ID: 30194898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
    Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
    J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of novel conjugates of podophyllotoxin and 5-FU as antineoplastic agents.
    Chen SW; Xiang R; Liu J; Tian X
    Bioorg Med Chem; 2009 Apr; 17(8):3111-7. PubMed ID: 19324555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic Agents. 585. Isolation of Bridelia ferruginea Anticancer Podophyllotoxins and Synthesis of 4-Aza-podophyllotoxin Structural Modifications.
    Pettit GR; Searcy JD; Tan R; Cragg GM; Melody N; Knight JC; Chapuis JC
    J Nat Prod; 2016 Mar; 79(3):507-18. PubMed ID: 26938998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and comparative evaluation of 4-oxa- and 4-aza-podophyllotoxins as antiproliferative microtubule destabilizing agents.
    Chernysheva NB; Tsyganov DV; Philchenkov AA; Zavelevich MP; Kiselyov AS; Semenov RV; Semenova MN; Semenov VV
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2590-3. PubMed ID: 22370267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cytotoxicity of racemic isodeoxypodophyllotoxin analogues with isoprene-derived side chains.
    Zhao Y; Feng JH; Ding HX; Xiong Y; Cheng CH; Hao XJ; Zhang YM; Pan YJ; Guéritte F; Wu XM; Bai H; Stöckigt J
    J Nat Prod; 2006 Aug; 69(8):1145-52. PubMed ID: 16933865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of new 4beta-5-Fu-substituted 4'-demethylepipodophyllotoxin derivatives.
    Zhang FM; Yao XJ; Tian X; Tu YQ
    Molecules; 2006 Nov; 11(11):849-57. PubMed ID: 18007391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
    Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
    Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.